These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2270019)

  • 1. [Type III hyperlipidemia].
    Nishiwaki M; Nakamura H
    Nihon Rinsho; 1990 Nov; 48(11):2546-51. PubMed ID: 2270019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial type III hyperlipoproteinemia].
    Kataoka S; Egusa G
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():69-73. PubMed ID: 11347154
    [No Abstract]   [Full Text] [Related]  

  • 3. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
    Borghini I; James RW; Pometta D
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and management of lipoprotein disorders.
    Schaefer EJ; Levy RI
    N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isoelectric focusing of apolipoproteins E in the VLDL lipoprotein fraction in the diagnosis of type III lipoproteinemia].
    Naruszewicz M; Nowicka G; Wiśniewska B; Kłosiewicz-Latoszek L
    Pol Arch Med Wewn; 1982; 67(5-6):235-41. PubMed ID: 7177885
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472
    [No Abstract]   [Full Text] [Related]  

  • 9. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
    Havel RJ
    Med Clin North Am; 1982 Mar; 66(2):441-54. PubMed ID: 7040846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
    Smelt AH; de Beer F
    Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis].
    Davignon J; Roederer G
    Union Med Can; 1988 Feb; 117(1):56-61. PubMed ID: 3376345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipoproteinemia type III: genetic basis and environmental factors, diagnosis, and treatment].
    Pocoví M; Garcés C; Casao E; Cenarro A; Civeira F
    Rev Clin Esp; 1992 Nov; 191(8):444-50. PubMed ID: 1488520
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Type III hyperlipoproteinemia in monoclonal IgM gammopathy].
    Hambrecht R; von Hodenberg E; Schuler G; Tischbirek K; Kübler W
    Dtsch Med Wochenschr; 1991 Nov; 116(45):1710-4. PubMed ID: 1935653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoproteins and atherosclerosis--study of apolipoprotein E].
    Taniguchi T; Yamasaki S
    Rinsho Byori; 1984 Jul; 32(7):772-9. PubMed ID: 6389939
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial apolipoprotein E deficiency.
    Schaefer EJ; Gregg RE; Ghiselli G; Forte TM; Ordovas JM; Zech LA; Brewer HB
    J Clin Invest; 1986 Nov; 78(5):1206-19. PubMed ID: 3771793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial type III hyperlipoproteinemia].
    Igarashi M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():333-9. PubMed ID: 17824053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.